Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 11, 2017 20:52 ET | Source: Nexvet Biopharma plc

Nexvet Biopharma plc ("Nexvet") Rule 2.10 Announcement

DUBLIN, Ireland, May 11, 2017 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET) today announced the following.In accordance with Rule 2.10 of the Irish Takeover Panel Act 1997, Takeover Rules, 2013...
May 11, 2017 05:30 ET | Source: Nexvet Biopharma plc

Nexvet Reports Financial Results for Third Quarter of Fiscal Year 2017

DUBLIN, Ireland, May 11, 2017 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET) today announced its financial results for the three and nine month periods ended March 31, 2017. Recent highlights: ...
February 22, 2017 05:30 ET | Source: Nexvet Biopharma plc

Nexvet to Present at the Cowen and Company 37th Annual Health Care Conference

DUBLIN, Ireland, Feb. 22, 2017 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET) today announced that its Chief Executive Officer, Dr. Mark Heffernan, is scheduled to present at the Cowen and...
February 10, 2017 05:30 ET | Source: Nexvet Biopharma plc

Nexvet Reports Financial Results for Second Quarter of Fiscal Year 2017

DUBLIN, Ireland, Feb. 10, 2017 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET) today announced its financial results for the three and six month periods ended December 31, 2016.Recent...
December 12, 2016 05:30 ET | Source: Nexvet Biopharma plc

Nexvet Announces Initiation of Pivotal Efficacy Study of Frunevetmab in Cats

DUBLIN, Ireland, Dec. 12, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET) today announced it has initiated a pivotal field efficacy and safety study of frunevetmab, the Company’s anti-nerve...
November 04, 2016 05:30 ET | Source: Nexvet Biopharma plc

Nexvet Reports Financial Results for First Quarter of Fiscal Year 2017

DUBLIN, Ireland, Nov. 04, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET) today announced its financial results for the three month period ended September 30, 2016. Recent highlights...
October 19, 2016 05:30 ET | Source: Nexvet Biopharma plc

Nexvet to Present at the 25th Annual Credit Suisse Healthcare Conference

DUBLIN, Ireland, Oct. 19, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapy developer, today announced that its Chief Executive Officer, Dr. Mark Heffernan, is...
September 02, 2016 05:30 ET | Source: Nexvet Biopharma plc

Nexvet Biopharma Reports Full Year Fiscal 2016 Results

DUBLIN, Ireland, Sept. 02, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapeutics company, today announced financial results for its 2016 fiscal year, which...
July 20, 2016 05:30 ET | Source: Nexvet Biopharma plc

Nexvet Announces Publication of Two Peer-Reviewed Journal Articles Profiling Frunevetmab (NV-02) and Presentation at the Veterinary Pain Short Course Conference

DUBLIN, Ireland, July 20, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapeutics company, today announced the recent publication of two peer-reviewed papers...
June 09, 2016 05:30 ET | Source: Nexvet Biopharma plc

Nexvet Presents Expanded Positive Clinical Data for Ranevetmab (NV-01) and Frunevetmab (NV-02) at ACVIM

DUBLIN, Ireland, June 09, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapeutics company, is today presenting expanded results regarding completed clinical...